How You Should Be Choosing Your Stocks
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades. We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.
John P. Bilbrey, insider at Elanco Animal Health

John P. Bilbrey Insider Information

John Bilbrey has served as a member of the Elanco board of directors since March 2019.

John Bilbrey served as the CEO and president of The Hershey Company until 2017. He also held multiple leadership roles throughout his 14-year tenure with the company, including chief operating officer and executive vice president, president of North America, and president of International Commercial group.

Bilbrey’s past professional experience includes positions as president and CEO of Danone Waters of North America, executive vice president of sales for Mission Foods, and more than 20 years of international consumer sales and marketing experience at Proctor & Gamble. Additionally, he is the owner and operator of Commercial Cattle Operations of Bilbrey Farms and Ranch.

Bilbrey served as non-executive chairman of The Hershey Company until 2018 and an independent director of McCormick & Company, Inc. until 2015. He currently is as an independent director on the board of Colgate-Palmolive Company. Bilbrey earned a bachelor’s degree in psychology from Kansas State University.

What is John P. Bilbrey's net worth?

The estimated net worth of John P. Bilbrey is at least $830,567.94 as of May 11th, 2022. Mr. Bilbrey owns 34,222 shares of Elanco Animal Health stock worth more than $830,568 as of May 22nd. This net worth evaluation does not reflect any other assets that Mr. Bilbrey may own. Learn More about John P. Bilbrey's net worth.

How do I contact John P. Bilbrey?

The corporate mailing address for Mr. Bilbrey and other Elanco Animal Health executives is 2500 INNOVATION WAY, GREENFIELD IN, 46140. Elanco Animal Health can also be reached via phone at (877) 352-6261 and via email at [email protected] Learn More on John P. Bilbrey's contact information.

Has John P. Bilbrey been buying or selling shares of Elanco Animal Health?

Within the last three months, John P. Bilbrey has bought $220,300.00 in Elanco Animal Health stock. 0 shares of the business's stock in a transaction that occurred on Sunday, May 22nd. Learn More on John P. Bilbrey's trading history.

Who are Elanco Animal Health's active insiders?

Elanco Animal Health's insider roster includes John Bilbrey (Director), Art Garcia (Director), Michael Harrington (Director), R. Hoover (Director), Jeffrey Simmons (CEO), and Todd Young (Insider). Learn More on Elanco Animal Health's active insiders.

Are insiders buying or selling shares of Elanco Animal Health?

During the last year, Elanco Animal Health insiders bought shares 7 times. They purchased a total of 45,558,788 shares worth more than $422,361,411.50. The most recent insider tranaction occured on May, 11th when Director John P Bilbrey bought 10,000 shares worth more than $220,300.00. Insiders at Elanco Animal Health own 6.4 % of the company. Learn More about insider trades at Elanco Animal Health.

Information on this page was last updated on 5/11/2022.

John P. Bilbrey Insider Trading History at Elanco Animal Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/11/2022Buy10,000$22.03$220,300.0034,222View SEC Filing Icon  
8/19/2020Buy9,580$26.20$250,996.008,016View SEC Filing Icon  
3/6/2020Buy3,000$25.15$75,450.008,016View SEC Filing Icon  
11/22/2019Buy3,766$26.58$100,100.282,783View SEC Filing Icon  
5/13/2019Buy7,750$32.39$251,022.50View SEC Filing Icon  
See Full Table

John P. Bilbrey Buying and Selling Activity at Elanco Animal Health

This chart shows John P Bilbrey's buying and selling at Elanco Animal Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Elanco Animal Health Company Overview

Elanco Animal Health logo
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Read More

Today's Range

Now: $24.27
Low: $23.19
High: $24.34

50 Day Range

MA: $25.45
Low: $20.82
High: $27.53

2 Week Range

Now: $24.27
Low: $20.51
High: $37.49

Volume

5,622,602 shs

Average Volume

5,254,802 shs

Market Capitalization

$11.51 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.74
Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward
Get the Details Now.